Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | ALPL | P05186 | 1/20 | 0.48 |
| ▸ | ALPI | P09923 | 1/20 | 0.48 |
| ▸ | ALPG | P10696 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | CASP3 | P42574 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28642636 | 0.85 | KDM4E (0.68) | MAPTLMNACYP1A2THRBALOX15 | |
| SCHEMBL9326802 | 0.83 | RAB9A (0.68) | MAPTCYP1A2KDM4EALDH1A1RAB9A | |
| SCHEMBL12714421 | 0.78 | SNCA (0.47) | MAPTLMNACYP1A2THRBALOX15 | |
| Bicarbonate SCHEMBL10758552 | 0.77 | APP (0.56) | MAPTLMNACYP1A2THRBALOX15 | |
| SCHEMBL10145461 | 0.74 | LMNA (0.39) | MAPTLMNACYP1A2KDM4EALDH1A1 | |
| SCHEMBL28427466 | 0.74 | MAPT (0.68) | MAPTLMNACYP1A2THRBALOX15 | |
| SCHEMBL14243596 | 0.71 | APP (0.68) | MAPTLMNACYP1A2THRBALOX15 | |
| SCHEMBL10175953 | 0.71 | SNCA (0.37) | MAPTLMNACYP1A2KDM4EALDH1A1 | |
| SCHEMBL10828855 | 0.70 | LMNA (0.58) | MAPTLMNACYP1A2THRBALOX15 | |
| SCHEMBL9169047 | 0.70 | MAPT (0.48) | MAPTMAPK1KDM4EALDH1A1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060105410-A1 | Sulfonate compound and fluorescent probe using the same | OSAKA INDUSTRIAL PROMOTION ORGANIZATION (JP) | 2006-05-18 | — | — | US | claimed |
| US-20060105412-A1 | Sulfonate compound and fluorescent probe using the same | OSAKA INDUSTRIAL PROMOTION ORGANIZATION (JP) | 2006-05-18 | — | — | US | claimed |
| EP-1650200-A1 | SULFONATE COMPOUND AND FLUORESCENT PROBE USING THE SAME | Osaka Industrial Promotion Organization (JP) | 2006-04-26 | — | — | EP | claimed |
| US-7491832-B2 | Sulfonate compound and fluorescent probe using the same | OSAKA INDUSTRIAL PROMOTION ORGANIZATION (JP) | 2009-02-17 | — | — | US | disclosed |
| US-7465814-B2 | Sulfonate compound and fluorescent probe using the same | OSAKA INDUSTRIAL PROMOTION ORGANIZATION (JP) | 2008-12-16 | — | — | US | disclosed |
| US-20060105412-A1 | Sulfonate compound and fluorescent probe using the same | OSAKA INDUSTRIAL PROMOTION ORGANIZATION (JP) | 2006-05-18 | — | — | US | disclosed |
| US-20060105410-A1 | Sulfonate compound and fluorescent probe using the same | OSAKA INDUSTRIAL PROMOTION ORGANIZATION (JP) | 2006-05-18 | — | — | US | disclosed |
| EP-1650200-A1 | SULFONATE COMPOUND AND FLUORESCENT PROBE USING THE SAME | Osaka Industrial Promotion Organization (JP) | 2006-04-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060105410-A1 | Sulfonate compound and fluorescent probe using the same | BRS3, NCOA3, NR4A3 | MAPT 4674/4885LMNA 2517/4885CYP1A2 2149/4885 |
| US-20060105412-A1 | Sulfonate compound and fluorescent probe using the same | SLCO1B3, CBR3, SLCO2B1 | MAPT 4468/4885LMNA 1764/4885CYP1A2 1177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.